Study Title
Dairy fat intake is associated with glucose tolerance, hepatic and systemic insulin sensitivity, and liver fat but not beta-cell function in humans
American Journal of Clinical Nutrition

Mario Kratz, Santica Marcovina, James E Nelson, Matthew M Yeh, Kris V Kowdley, Holly S Callahan, Xiaoling Song, Chongzhi Di, and Kristina M Utzschneider


Plasma phospholipid concentrations of trans-palmitoleic acid (trans-16:1n27), a biomarker of dairy fat intake, are inversely associated with incident type 2 diabetes in 2 US cohorts. Objective: The objective was to investigate whether the intake of trans-16:1n27 in particular, or dairy fat in general, is associated with glucose tolerance and key factors determining glucose tolerance.
A cross-sectional investigation was undertaken in 17 men and women with nonalcoholic fatty liver disease and 15 body mass index (BMI)- and age-matched controls. The concentrations of trans-16:1n27 and 2 other biomarkers of dairy fat intake, 15:0 and 17:0, were measured in plasma phospholipids and free fatty acids (FFAs). Liver fat was estimated by computed tomography– derived liver-spleen ratio. Intravenous-glucose-tolerance tests and oral- glucose-tolerance test (OGTT) and hyperinsulinemic-euglycemic clamps were performed to assess b-cell function and hepatic and systemic insulin sensitivity.
In multivariate analyses adjusted for age, sex, and BMI, phospholipid 17:0, phospholipid trans-16:1n27, FFA 15:0, and FFA 17:0 were inversely associated with fasting plasma glucose, the area under the curve for glucose during an OGTT, and liver fat. Phospholipid trans-16:1n27 was also positively associated with hepatic and systemic insulin sensitivity. None of the biomarkers were associated with b-cell function. The associations between dairy fat intake and glucose tolerance were attenuated by adjusting for insulin sensitivity or liver fat, but strengthened by adjusting for b-cell function.
Although we cannot rule out reverse causation, these data support the hypothesis that dairy fat improves glucose tolerance, possibly through a mechanism involving improved hepatic and systemic insulin sensitivity and reduced liver fat.

April 16, 2014
View study

Share This

Related Topics

Insulin SensitivityDairy

Dr. Perlmutter is one of the leading lights in medicine today, illuminating the path for solving chronic illness

Mark Hyman, MD